ANNOUNCEMENTFeasibility Study Agreement • February 2nd, 2023Contract TypeFeasibility Study AgreementFiledFebruary 2nd, 2023Taiwan Liposome Company and Ablynx entered into a Feasibility Study Agreement for Nanobody-Immunoliposome Development
Taiwan Liposome Company and Ablynx entered into a Feasibility Study Agreement for Nanobody-Immunoliposome Development
Draft, Review & Redline at the Speed of AI